Login

Understand Stock

Sign in or create a free account to unlock 10 years of data, build your watchlist, create alerts and more.

Sign in

$ALMR

$21.50 +$0.56 (2.67%)

Deep Research with AI Research

Overview

$ALMR Overview Financials SEC Filings Executives News

Specialized Tools

Valuations P Insider Transactions P Congressional Trades P

$ALMR News

May 12, 2026

TD Cowen Initiates Coverage On Alamar Biosciences with Buy Rating, Announces Price Target of $30

10:35 AM • Benzinga

JP Morgan Initiates Coverage On Alamar Biosciences with Overweight Rating, Announces Price Target of $30

08:27 AM • Benzinga

Stifel Initiates Coverage On Alamar Biosciences with Buy Rating, Announces Price Target of $28

06:46 AM • Benzinga

May 08, 2026

Alamar Biosciences Q1 EPS $(1.74), Sales $26.035M

08:10 AM • Benzinga

April 20, 2026

Qiming Venture Partners-Backed Alamar Biosciences Lists On NASDAQ, Issues Shares At $17, Opens At $22.6 With $1.5B Valuation

03:47 AM • Benzinga

Qiming Venture Partners-Backed Alamar Biosciences Lists On NASDAQ, Issues Shares At $17, Opens At $22.6 With $1.5B Valuation

03:47 AM • Benzinga

April 17, 2026

Alamar Biosciences IPO Opens For Trade At $22.60/Share; IPO Priced At $17/Share On 11.25M Shares

12:35 PM • Benzinga

Alamar Biosciences IPO Indicating $22.50/Share On 830K Shares; IPO Priced At $17/Share On 11.25M Shares

12:12 PM • Benzinga

Alamar Biosciences IPO Indicating $22/Share On 523K Shares; IPO Priced At $17/Share On 11.25M Shares

11:43 AM • Benzinga

Alamar Biosciences IPO Indicating $20/Share On 417K Shares; IPO Priced At $17/Share On 11.25M Shares

11:32 AM • Benzinga

Trading Halt: Halt status updated at 11:00:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

11:00 AM • Benzinga

Loading...